Organization type


  • Biotech
  • Material supplier
  • Private research organization

Early phases


  • Biomarker identification
  • Omics
    • Genomics
    • Metabolomics
    • Phenomics
  • Systems biology
  • Target identification – new biological hypothesis
  • Target validation – Hypothesis verification

Screening


  • Assay development
    • In vitro screening models
  • Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)

Optimization phases


  • In vitro biochemical models(including assay/model development and testing)
  • In vitro cellular and organotypic 3D models (including assay/model development and testing)
  • Mechanism of action (MoA) assessment
    • Functional cellular panels
    • Selectivity panels
  • Medicinal chemistry programs for hit to lead and lead optimization
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • ADME / DMPK
    • Safety
    • Toxicology

Functional areas


  • Material / reagents supply
  • Molecular and cellular biology
    • Flow cytometry
    • Imaging / High content screening
    • qPCR

Terapeutic areas


  • Autoimmunity / Inflammation
  • Cancer
  • Cardiovascular
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Ophthalmology / Optometry

Additional activities


  • Industry associations